Gerson Jhonatan Rodrigues

Prof. Dr. Gerson Jhonatan Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MCMichele M. Castro
Michele M. Castro
ERElen Rizzi
Elen Rizzi
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
CCCarla S. Ceron
Carla S. Ceron
LBLusiane M. Bendhack
Lusiane M. Bendhack
JTJose E. Tanus-Santos
Jose E. Tanus-Santos

24 April 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
PGPaulo Marcos da Matta Guedes
Paulo Marcos da Matta Guedes
FGFredy Roberto Salazar Gutierrez
Fredy Roberto Salazar Gutierrez
GSGrace Kelly Silva
Grace Kelly Silva
RDRenata Dellalibera-Joviliano
Renata Dellalibera-Joviliano
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
JSJoão Santana da Silva
João Santana da Silva
Myocardium damage during Chagas' disease results from the immunological imbalance between pro- and production of anti-inflammatory cytokines and has been explained based on the Th1–Th2 dichotomy and regulatory T cell activity. Recently, we demonstrated that IL-17 produced during experimental T. cruzi infection regulates Th1 cells differentiation and parasite induced myocarditis. Here, we investigated the role of IL-17 and regulatory T cell during human Chagas' disease. First, we observed CD4+IL-17+ T cells in culture of peripheral blood mononuclear cells (PBMC) from Chagas' disease patients and we evaluated Th1, Th2, Th17 cytokine profile production in the PBMC cells from Chagas' disease patients (cardiomyopathy-free, and with mild, moderate or severe cardiomyopathy) cultured with T. cruzi antigen. Cultures of PBMC from patients with moderate and severe cardiomyopathy produced high levels of TNF-α, IFN-γ and low levels of IL-10, when compared to mild cardiomyopathy or cardiomyopathy-free patients. Flow cytometry analysis showed higher CD4+IL-17+ cells in PBMC cultured from patients without or with mild cardiomyopathy, in comparison to patients with moderate or severe cardiomyopathy. We then analyzed the presence and function of regulatory T cells in all patients. All groups of Chagas' disease patients presented the same frequency of CD4+CD25+ regulatory T cells. However, CD4+CD25+ T cells from patients with mild cardiomyopathy or cardiomyopathy-free showed higher suppressive activity than those with moderate and severe cardiomyopathy. IFN-γ levels during chronic Chagas' disease are inversely correlated to the LVEF (P = 0.007, r = −0.614), while regulatory T cell activity is directly correlated with LVEF (P = 0.022, r = 0.500). These results indicate that reduced production of the cytokines IL-10 and IL-17 in association with high levels of IFN-γ and TNF-α is correlated with the severity of the Chagas' disease cardiomyopathy, and the immunological imbalance observed may be causally related with deficient suppressor activity of regulatory T cells that controls myocardial inflammation. Dilated cardiomyopathy is one of the clinical forms of Chagas' disease (CD) after the infection caused by the parasite Trypanosoma cruzi. Even though strategies adopted in most Latin-American countries in the last decades towards vector control have been effective in reducing the incidence of CD, active transmission is maintained in some regions, and secondary prevention approaches are still required for the infected patients, mostly because the specific anti-parasitic medications are toxic and perhaps of limited efficacy in chronically infected individuals. Moreover, there are no markers to predict the risk of developing dilated cardiomyopathy in asymptomatic, chronically infected patients, although the failure in the mechanisms that control the immune response can be involved in the development of Chagas' heart disease. In this study we show that preserved activity of regulatory T cells and the production of the cytokine IL-17 are connected with a more benign evolution of the disease, which brings a new understanding on the mechanisms associated with progression of CD.

1 June 2008 in Nitric Oxide
Verified
Journal Article
Closed access
DBDaniela Bonaventura
Daniela Bonaventura
CLClaure N Lunardi
Claure N Lunardi
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
MNMário A. Neto
Mário A. Neto
LBLusiane M. Bendhack
Lusiane M. Bendhack

1 March 2012 in Nitric Oxide
Verified
Journal Article
Closed access
MCMichele M. Castro
Michele M. Castro
ERElen Rizzi
Elen Rizzi
CCCarla S. Ceron
Carla S. Ceron
DGDanielle A. Guimaraes
Danielle A. Guimaraes
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
JTJose Eduardo Tanus-Santos
Jose Eduardo Tanus-Santos

25 December 2007 in Nitric Oxide
Verified
Journal Article
Closed access
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
CLClaure N Lunardi
Claure N Lunardi
RLR.G. Lima
R.G. Lima
CSC.X. Santos
C.X. Santos
FLF.R.M. Laurindo
F.R.M. Laurindo
LBLusiane Bendhack
Lusiane Bendhack

26 April 2010 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
PGPaulo Marcos da Matta Guedes
Paulo Marcos da Matta Guedes
FOFabiana S Oliveira
Fabiana S Oliveira
FGFredy Rs Gutierrez
Fredy Rs Gutierrez
GSGrace Kelly da Silva
Grace Kelly da Silva
GRGerson Jhonatan Rodrigues
Gerson Jhonatan Rodrigues
JSJoão Santana da Silva
João Santana da Silva